Lynne E. Maquat

Last updated
Lynne Maquat
Lynne Maquat, Ph.D.jpg
Born
Lynne Elizabeth Maquat
NationalityAmerican
Alma mater University of Wisconsin–Madison
University of Connecticut
Known forRNA biology in human diseases
Awards Gruber Prize in Genetics (2023)
Wolf Prize in Medicine (2021)
FASEB Excellence in Science Award (2018)
Wiley Prize (2018)
Gairdner Foundation International Award (2015)
William C. Rose Award (2014)
Member of the National Academy of Sciences (2011)
Scientific career
Fields Biochemistry
Molecular biology
Cell biology
Institutions University of Rochester
Doctoral advisor William S. Reznikoff[ citation needed ]
Website www.urmc.rochester.edu/labs/maquat-lab

Lynne Elizabeth Maquat is an American biochemist and molecular biologist whose research focuses on the cellular mechanisms of human disease. She is an elected member of the American Academy of Arts and Sciences, [1] the National Academy of Sciences [2] and the National Academy of Medicine. [3] She currently holds the J. Lowell Orbison Endowed Chair and is a professor of biochemistry and biophysics, pediatrics and of oncology [4] at the University of Rochester Medical Center. Professor Maquat is also Founding Director of the Center for RNA Biology [5] and Founding Chair of Graduate Women in Science [6] at the University of Rochester. [7]

Contents

Education

Maquat graduated magna cum laude with a Bachelor of Science degree in biology from the University of Connecticut; her thesis was in cell biology. She received her PhD in biochemistry from the University of Wisconsin. [8]

Career and research

Maquat did postdoctoral research at the McArdle Laboratory for Cancer Research. She has published more than 130 papers in peer-reviewed journals [9] and edited numerous books.

Lynne Elizabeth Maquat is the J. Lowell Orbison Endowed Chair, Professor of Biochemistry & Biophysics who holds concomitant appointments in pediatrics and in oncology, Founding Director of the Center for RNA Biology, and Founding Chair of Graduate Women in Science at the University of Rochester in Rochester, New York. After obtaining her PhD in biochemistry from the University of Wisconsin-Madison and undertaking post-doctoral work at the McArdle Laboratory for Cancer Research, she joined Roswell Park Comprehensive Cancer Center before moving to the University of Rochester. Maquat's research focuses on the molecular basis of human diseases, with particular interest in mechanisms of mRNA decay. Maquat discovered nonsense-mediated mRNA decay (NMD) in 1981 and, subsequently, the exon-junction complex (EJC) and how the EJC marks mRNAs for a quality-control “pioneer” round of protein synthesis. She also discovered Staufen-mediated mRNA decay, which mechanistically competes with NMD and, by so doing, new roles for short interspersed elements and long non-coding RNAs. Additionally, she has defined a new mechanism by which microRNAs are degraded, thereby regulating mRNAs so as to promote the cell cycle. Maquat is an elected Fellow of the American Association for the Advancement of Science (2006); an elected Member of the American Academy of Arts & Sciences (2006), the National Academy of Sciences (2011), and the National Academy of Medicine (2018); and a Batsheva de Rothschild Fellow of the Israel Academy of Sciences & Humanities (2012-3). She received the William C. Rose Award from the American Society for Biochemistry & Molecular Biology (2014); a Canada Gairdner International Award (2015); the international RNA Society Lifetime Achievement Award in Service (2010) and in Science (2017); the Vanderbilt Prize in Biomedical Science (2017); the FASEB Excellence in Science Award (2018); the Wiley Prize in Biomedical Sciences from Rockefeller University (2018); the International Union of Biochemistry and Molecular Biology Medal (2019); the Wolf Prize in Medicine from the Wolf Foundation in Israel (2021); and the Warren Alpert Foundation Prize from Harvard Medical School (2021). Maquat is well known for her efforts to promote women in science. In 2003, she founded the University of Rochester Graduate Women in Science program to address the "leaky pipeline" in science, which describes how fewer women than men who earn a Ph.D. degree in science go on to use that degree in a career.

Elected fellowships/memberships

Awards and honors

Related Research Articles

<span class="mw-page-title-main">Bonnie Bassler</span> American molecular biologist

Bonnie Lynn Bassler is an American molecular biologist; the Squibb Professor in Molecular Biology and chair of the Department of Molecular Biology at Princeton University; and a Howard Hughes Medical Institute Investigator. She has researched cell-to-cell chemical communication in bacteria and discovered key insights into the mechanism by which bacteria communicate, known as quorum sensing. She has contributed to the idea that disruption of chemical signaling can be used as an antimicrobial therapy.

<span class="mw-page-title-main">H. Robert Horvitz</span> American biologist

Howard Robert Horvitz ForMemRS NAS AAA&S APS NAM is an American biologist best known for his research on the nematode worm Caenorhabditis elegans, for which he was awarded the 2002 Nobel Prize in Physiology or Medicine, together with Sydney Brenner and John E. Sulston, whose "seminal discoveries concerning the genetic regulation of organ development and programmed cell death" were "important for medical research and have shed new light on the pathogenesis of many diseases".

<span class="mw-page-title-main">Elizabeth Blackburn</span> Australian-born American biological researcher

Elizabeth Helen Blackburn, is an Australian-American Nobel laureate who is the former president of the Salk Institute for Biological Studies. Previously she was a biological researcher and professor of biology and physiology at the University of California, San Francisco, who studied the telomere, a structure at the end of chromosomes that protects the chromosome. In 1984, Blackburn co-discovered telomerase, the enzyme that replenishes the telomere, with Carol W. Greider. For this work, she was awarded the 2009 Nobel Prize in Physiology or Medicine, sharing it with Greider and Jack W. Szostak, becoming the first Australian woman Nobel laureate. She also worked in medical ethics, and was controversially dismissed from the Bush administration's President's Council on Bioethics.

Ronald Mark Evans is an American Biologist, Professor and Head of the Salk’s Gene Expression Laboratory, and the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California and a Howard Hughes Medical Institute Investigator. Dr. Ronald M. Evans is known for his original discoveries of nuclear hormone receptors (NR), a special class of transcriptional factor, and the elucidation of their universal mechanism of action, a process that governs how lipophilic hormones and drugs regulate virtually every developmental and metabolic pathway in animals and humans. Nowadays, NRs are among the most widely investigated group of pharmaceutical targets in the world, already yielding benefits in drug discovery for cancer, muscular dystrophies, osteoporosis, type II diabetes, obesity, and cardiovascular diseases. His current research focuses on the function of nuclear hormone signaling and their function in metabolism and cancer.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

<span class="mw-page-title-main">Robert G. Roeder</span>

Robert G. Roeder is an American biochemist. He is known as a pioneer scientist in eukaryotic transcription. He discovered three distinct nuclear RNA polymerases in 1969 and characterized many proteins involved in the regulation of transcription, including basic transcription factors and the first mammalian gene-specific activator over five decades of research. He is the recipient of the Gairdner Foundation International Award in 2000, the Albert Lasker Award for Basic Medical Research in 2003, and the Kyoto Prize in 2021. He currently serves as Arnold and Mabel Beckman Professor and Head of the Laboratory of Biochemical and Molecular Biology at The Rockefeller University.

<span class="mw-page-title-main">Charles David Allis</span> American molecular biologist (1951-2023)

Charles David Allis was an American molecular biologist, and the Joy and Jack Fishman Professor at the Rockefeller University. He was also the Head of the Laboratory of Chromatin Biology and Epigenetics, and a professor at the Tri-Institutional MD–PhD Program.

<span class="mw-page-title-main">Joan A. Steitz</span> American biochemist

Joan Elaine Argetsinger Steitz is Sterling Professor of Molecular Biophysics and Biochemistry at Yale University and Investigator at the Howard Hughes Medical Institute. She is known for her discoveries involving RNA, including ground-breaking insights into how ribosomes interact with messenger RNA by complementary base pairing and that introns are spliced by small nuclear ribonucleic proteins (snRNPs), which occur in eukaryotes. In September 2018, Steitz won the Lasker-Koshland Award for Special Achievement in Medical Science. The Lasker award is often referred to as the 'American Nobel' because 87 of the former recipients have gone on to win Nobel prizes.

<span class="mw-page-title-main">Carol W. Greider</span> American molecular biologist and Nobel laureate

Carolyn Widney Greider is an American molecular biologist and Nobel laureate. She joined the University of California, Santa Cruz as a Distinguished Professor in the department of molecular, cell, and developmental biology in October 2020.

<span class="mw-page-title-main">Arthur L. Horwich</span> American biologist (born 1951)

Arthur L. Horwich is an American biologist and Sterling Professor of Genetics and Pediatrics at the Yale School of Medicine. Horwich has also been a Howard Hughes Medical Institute investigator since 1990. His research into protein folding uncovered the action of chaperonins, protein complexes that assist the folding of other proteins; Horwich first published this work in 1989.

Franz-Ulrich Hartl is a German biochemist and Managing Director of the Max Planck Institute of Biochemistry. He is known for his pioneering work in the field of protein-mediated protein folding and is a recipient of the 2011 Lasker Award along with Arthur L. Horwich.

Nahum Sonenberg, is an Israeli Canadian microbiologist and biochemist. He is a James McGill professor of biochemistry at McGill University in Montreal, Quebec, Canada. He was an HHMI international research scholar from 1997 to 2011 and is now a senior international research scholar. He is best known for his seminal contributions to our understanding of translation, and notable for the discovery of the mRNA 5' cap-binding protein, eIF4E, the rate-limiting component of the eukaryotic translation apparatus.

<span class="mw-page-title-main">Shizuo Akira</span>

Shizuo Akira is a professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, most significantly in the area of innate host defense mechanisms.

The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee’s significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.

<span class="mw-page-title-main">Aviv Regev</span> Bioinformatician

Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.

Stephen Joseph Elledge is an American geneticist. He is currently the Gregor Mendel Professor of Genetics and Medicine in the Department of Genetics at Harvard Medical School and in the Division of Genetics at the Brigham and Women's Hospital, and is an Investigator with the Howard Hughes Medical Institute. He earned his B.Sc. in chemistry from the University of Illinois at Urbana–Champaign and his Ph.D. in biology from MIT. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage. He is a member of the National Academy of Sciences and has been a Howard Hughes Medical Institute (HHMI) investigator since 1993.

<span class="mw-page-title-main">Jennifer Doudna</span> American biochemist and Nobel laureate (born 1964)

Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.

<span class="mw-page-title-main">Emmanuelle Charpentier</span> French microbiologist, biochemist and Nobel laureate

Emmanuelle Marie Charpentier is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing". This was the first science Nobel Prize ever won by two women only.

<span class="mw-page-title-main">Adrian Krainer (scientist)</span> Uruguayan neuroscientist

Adrian Robert Krainer is a Uruguayan-American biochemist and molecular geneticist known for his research into RNA gene-splicing. Krainer holds the St. Giles Foundation Professorship at Cold Spring Harbor Laboratory in Laurel Hollow, New York.

References

  1. "Membership". www.amacad.org. Retrieved 2017-09-22.
  2. "Lynne Maquat". National Academy of Sciences Online. Retrieved 2017-09-22.
  3. "National Academy of Medicine Elects 80 New Members - National Academy of Medicine". National Academy of Medicine. 2017-10-16. Retrieved 2018-01-02.
  4. "Lynne Elizabeth Maquat, Ph.D. - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2017-09-22.
  5. "Center for RNA Biology: From Genome to Therapeutics - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2017-09-22.
  6. "Graduate Women In Science (GWIS) - Students - Education - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2017-09-22.
  7. Lynne E. Maquat publications indexed by Google Scholar OOjs UI icon edit-ltr-progressive.svg
  8. Emily Boynton; Christine Roth. "No Boundaries: The Spirit and Science of Lynne Maquat". Rochester Medicine Magazine. University of Rochester.
  9. "Publications by Lynne Elizabeth Maquat, Ph.D. - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2017-09-22.
  10. "Lynne Maquat wins 2014 Athena award". Rochester Democrat and Chronicle. Retrieved 2018-10-23.
  11. "Lynne Maquat wins 2014 Athena award". ROC. Retrieved 2018-10-23.
  12. "2014 ASBMB Annual Awards: William C. Rose Award". www.asbmb.org. Retrieved 2017-09-22.
  13. "Index of Winners - Gairdner Foundation". Gairdner Foundation. Retrieved 2017-09-22.
  14. "Maquat named to receive Vanderbilt Prize in Biomedical Science". Vanderbilt University. Retrieved 2018-01-02.
  15. "Maquat Receives Lifetime Achievement Award in Science from International RNA Society - ASCB". ASCB. 2017-06-14. Retrieved 2018-10-23.
  16. "FASEB 2018 Excellence in Science Award Recipient Announced". FASEB. Retrieved 2017-09-22.
  17. "The 17th Annual Wiley Prize in Biomedical Sciences Awarded for Elucidating the Mechanism of Nonsense-Mediated Messenger RNA Decay | Wiley News Room – Press Releases, News, Events & Media". newsroom.wiley.com. Retrieved 2018-02-26.
  18. "IUBMB Jubilee Lecturers | Biochemistry and Molecular Biology, International Union". International Union of Biochemistry and Molecular Biology. Retrieved 2019-10-30.
  19. Wolf Prize in Medicine 2021
  20. "Lynne Maquat Wins Warren Alpert Foundation Prize".
  21. "Workhorse Molecule at Center Stage". hms.harvard.edu. Retrieved 2021-05-03.
  22. "2023 Gruber Genetics Prize | Gruber Foundation". gruber.yale.edu. Retrieved 2023-02-23.